Cyclerion Therapeutics Inc. (CYCN) stock rises during pre-market trading. Here’s to know why?
Cyclerion Therapeutics Inc. (NASDAQ: CYCN) stock declined by 1.25% at the last close while the CYCN stock price gains by 15.56% in the pre-market trading session. Cyclerion Therapeutics is a clinical-stage biopharmaceutical firm dedicated to developing therapies that help people regain cognitive function. Cyclerion is developing CNS-penetrant, first-in-class sGC stimulators that control a crucial node […]
Why Cyclerion Therapeutics, Inc. (CYCN) stock is falling today?
Shares of Cyclerion Therapeutics, Inc. (CYCN) were continued to fall in the pre-market trading session today on April 28, 2021, after recording the drop of 17.95% at the previous closing. CYCN stock price was down by 2.34% today to drop at $2.50 a share at the time of this writing. The pipeline progress discussed by […]